课题基金 / 基金详情

ENZYMOLOGY

ENZYMOLOGY
酶学
批准号:
6346010
负责人:
RAYMOND J BUDDE
金额:
$14.64万
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-09-30 至 2002-03-31

项目摘要

项目成果

RAYMOND J BUDDE的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This Laboratory Program represents the biochemistry section of a multidisciplinary effort to develop specific inhibitors against Src. This Program will be responsible for producing recombinant Src and other PTKs to (1) screen inhibitors, (2) determine the affinity of "hits" identified in the screen, (3) determine the specificity of the "hits" identified in the screen, and (4) perform structural studies of the Src active site. This laboratory program serves as a screen between the two synthetic chemistry laboratories and the two biological testing laboratories which functions to narrow down the thousands of compounds synthesized to those which are worth studying for biological efficacy. In addiction, it aids the synthetic chemistry sections in choosing which analogs to consider for synthesis and testing. The biochemistry lab has developed an infrastructure to produce recombinant PTKs and a high-through put screening of combinatorial libraries.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
HIGHLY INNOVATED TARGETED THERAPY OF MELANOMA
  • 批准号:
    9202154
  • 项目类别:
  • 资助金额:
    $28.12万
  • 财政年份:
    2016
  • 负责人:
    RAYMOND J BUDDE
  • 依托单位:
Preclinical development of WP1066, an effective inhibitor of STAT3 activation for
  • 批准号:
    8119433
  • 项目类别:
  • 资助金额:
    $41.03万
  • 财政年份:
    2008
  • 负责人:
    RAYMOND J BUDDE
  • 依托单位:
Inhibition of STAT-3 to stimulate immune function for GBM
  • 批准号:
    7394119
  • 项目类别:
  • 资助金额:
    $14.7万
  • 财政年份:
    2008
  • 负责人:
    RAYMOND J BUDDE
  • 依托单位:
Preclinical development of WP1066, an effective inhibitor of STAT3 activation for
  • 批准号:
    8003416
  • 项目类别:
  • 资助金额:
    $43.03万
  • 财政年份:
    2008
  • 负责人:
    RAYMOND J BUDDE
  • 依托单位:
海外基金